Juvenile diabetes research foundation artificial pancreas consortium update.
نویسندگان
چکیده
A mechanical means to restore euglycemica in diabetes has long been considered achievable, yet a portable and widely adopted artificial pancreas system has not been realized.1,2 The Artificial Pancreas Consortium was established in 2006 as part of the Juvenile Diabetes Research Foundation International (JDRF) Artificial Pancreas Project, a multimillion dollar, multiyear initiative with a mission to accelerate the development of systems for automated control of blood glucose in patients with diabetes. Consortium investigators seek to research and develop strategies, which can be commercialized, that will confer the long-term benefits of improved glycemic control by combining novel automated control algorithms and hormone therapies with continuous glucose monitors and pump devices.
منابع مشابه
Predicting postprandial glucose excursions using gaussian process regression.
In recent years, continuous glucose measurement (CGM) devices have increased the quantity of data available to a patient and care team by an order of magnitude. We believe that a thorough evaluation of the control strategy of a patient or artificial pancreas can only occur when blood glucose measurements can be placed in the context of the patient’s behaviors. Exciting results from the Juvenile...
متن کاملOutcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report
Research on and commercial development of the artificial pancreas (AP) continue to progress rapidly, and the AP promises to become a part of clinical care. In this report, members of the JDRF Artificial Pancreas Project Consortium in collaboration with the wider AP community 1) advocate for the use of continuous glucose monitoring glucose metrics as outcome measures in AP trials, in addition to...
متن کاملGuest Editors
S P E C T R U M . D I A B E T E S J O U R N A L S . O R G L aurie Quinn, PhD, RN, FAAN, FAHA, CDE, is a clinical professor, and Cynthia Fritschi, PhD, RN, CDE, is an assistant professor of nursing at the University of Illinois College of Nursing in Chicago. Dr. Quinn has maintained an ongoing research program focusing on improving the health of people with diabetes and reducing the burden of di...
متن کاملType 1 Diabetes—Reaping the Rewards of a Targeted Research Investment
The Diabetes Control and Complications Trial (DCCT) precipitated a major research effort to develop new approaches to achieve near-normal glycemic control in real-world settings in people with type 1 diabetes. Toward that end, a unique funding stream from the U.S. Congress-the Special Statutory Funding Program for Type 1 Diabetes Research-has provided nearly $2.5 billion for research into the p...
متن کاملModeling the distribution of insulin in pancreas
Maintenance of adequate pancreatic β-cell mass, via suppression of programmed cell death and/or sustained proliferation is critical for the prevention or delay of diabetes mellitus. It is well established that insulin potently activates mitogenic and anti-apoptotic signaling cascades in cultured β-cells. Furthermore, loss of β-cell insulin receptors is sufficient to induced type 2 diabetes in a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Journal of diabetes science and technology
دوره 3 5 شماره
صفحات -
تاریخ انتشار 2009